Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-pentixafor PET/CT in Hematological Malignancies
NCT05255926Recruiting
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- Mar 2022
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Zhongnan Hospital of Wuhan University. Primary endpoints: Diagnostic Accuracy of 68Ga-pentixafor PET/CT Compared to 18F-FDG PET/CT at 2 years, Concordance of [68Ga]Ga-pentixafor PET/CT with Standard Clinical Staging Systems at 2 years and 3 more. Started Mar 2022; status: recruiting.
Beyond the preview
Go deeper on NCT05255926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05255926.